MABT388 Sigma-AldrichAnti-ADAM 17 Antibody, clone 16C11.1 | MABT388
This mouse Monoclonal Anti-ADAM 17 Antibody, clone 16C11.1, Cat. No. MABT388 detects levels of ADAM17, and has been published and validated for use in Western Blotting, Immunohistochemistry (Paraffin).
More>> This mouse Monoclonal Anti-ADAM 17 Antibody, clone 16C11.1, Cat. No. MABT388 detects levels of ADAM17, and has been published and validated for use in Western Blotting, Immunohistochemistry (Paraffin). Less<<Recommended Products
Overview
| Replacement Information | 
|---|
Key Spec Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type | 
|---|---|---|---|---|
| H | WB, IH(P) | M | Purified | Monoclonal Antibody | 
| References | 
|---|
| Product Information | |
|---|---|
| Format | Purified | 
| Presentation | Purified mouse monoclonal IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. | 
| Quality Segment | MQ100 | 
| Physicochemical Information | 
|---|
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. | 
| Packaging Information | |
|---|---|
| Material Size | 100 μg | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade ITEM Number | |
|---|---|
| Catalogue Number | GTIN | 
| MABT388 | 04055977176506 | 
Documentation
Anti-ADAM 17 Antibody, clone 16C11.1 | MABT388 SDS
| Title | 
|---|
Anti-ADAM 17 Antibody, clone 16C11.1 | MABT388 Certificates of Analysis
| Title | Lot Number | 
|---|---|
| Anti-ADAM 17, clone 16C11.1 - 3313716 | 3313716 | 
| Anti-ADAM 17, clone 16C11.1 -Q2581258 | Q2581258 | 
Technical Info
| Title | 
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System | 
| White Paper: Further considerations of antibody validation and usage. | 



  
